Rezolute (RZLT) stock

Rare disease therapies , market cap $352M

Rare disease therapies

Worth $352M

$4.02

+3.88%

As of Tuesday's close · Live for Pro members at the open

Quality Score

-4

Poor

In its industry

#81of 90

Pharma

Checks firing

2of 14

Choppy

From 52-week high

-64.9%

under its best in a year

RZLT's Quality Score rose 3 points on Tue, Nov 10, to -4. 1.3% more shares outstanding than a year ago.

Follow RZLT's trial news. Pro members can get an alert when Rezolute files news, and see its trials, share raises, and its CEO's filings.

Get an alert when RZLT files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextEnd of 2026“is in progress and topline results are expected before the end of 2026.”Trial data · SEC filing · Sep 24

Cash$90M, about 5 quarters at the last year's spendingOn Sep 30

Why is RZLT up?

Up 3.9% today, while its health care peers are down 1.0%; no story names it yet.

Behind the market

Down 61% in a year while the S&P 500 rose 12%; up 355% over three years.

Its $90.0M in cash covers about 5 quarters at the past year's pace of $16.5M a quarter.
Arithmetic on filed figures, not a forecast.

Sources: Price history, Nov 9, 2026; Latest balance sheet, Nov 5, 2026

The other side, the timeline, and its peers, for Pro members.

Key facts on RZLT

Key facts on RZLT
Holding it back	A $78M loss wider than $77M a year earlier
Latest filing	8-K, Nov 5 Reported its quarterly results

1 more reason behind RZLT's -4, free with an account →2 more reasons behind RZLT's -4, for Pro members.

RZLT in the news

TodayNo story names it yet.

What's next

Thu Nov 19: Jefferies 17th Annual London Global…Investor conference · date confirmed.

1 more date ahead: the meeting, for Pro members.

Cash$90M, about 5 quarters at the last year's spendingOn Sep 30

RZLT catalysts

Coming up

After its last 4 reports it closed +3.1% on average, higher 3 of 4 times.

What's next for RZLT, and how long its cash lasts

Next step the company has named

End of 2026“is in progress and topline results are expected before the end of 2026.”Trial data · SEC filing · Sep 24

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway: Tumor HIPhase 3 · Recruiting · 16 people · main data estimated Sep 2027 · NCT06881992

1 more trial, 2 more milestones and 50 filings, for Pro members.

Cash runway Sep 30 balance sheet

About 5 quarters

$90M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Nov 5, 2026)
At-the-market share sales program (S-3, filed Nov 5, 2026)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

CFO Daron Evans bought 10,000 shares on Mar 30.

From Form 4: open-market buys and sales only.

Get an alert when Nevan Elam buys or sells

For Pro members: every trade, and Nevan Elam’s 9 filings and quotes.

Get an alert when RZLT files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why RZLT scores -4

Poorfor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

+2Chart checks 2 of 14 firing right now, one point each
−3Long-term trend below a falling 200-⁠day average, down over one year, down over two years

Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Run-up, Size, Growth, Dilution, Persistence, and News.

What every line is worth, and the reason behind it, on RZLT and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:45 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when RZLT's Quality Score turns up

A free account. No card.

How RZLT ranks in Pharma

RZLT is #81 of 90 by Quality Score.

How RZLT ranks in Pharma
Rank	Stock	Checks	Quality Score
1	ABBVAbbVie	10/14	23
2	LLYEli Lilly	8/14	21
3	PFEPfizer	6/14	17
	RDYDr. Reddy's Laboratories		Open for its score
	ROIVRoivant Sciences		Open for its score
	SIGASIGA Technologies		Open for its score
	SLSSELLAS Life Sciences		Open for its score
81	RZLTRezolute	2/14	-4

When does RZLT report earnings, and what happens after?

Expected to report Thu Feb 11, after the close (in 93 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What RZLT reported on Nov 5, 2026

The quarter

A loss of $0.18 a share, from $0.18.

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

RZLT's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

The numbers

Market value: $352M; today

No analyst estimates on Breakaway: every figure here is filed.

The whole report on RZLT: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 4

+5.8%+0.9%-1.0%+6.6%

Feb 12May 12Sep 24Nov 5

Reported	When	Gap	Reaction	5 days
Nov 5, 2026After close	After close	+0.8%	+6.6%	not yet
Sep 24, 2026After close	After close	+1.3%	-1.0%	+3.3%
May 12, 2026After close	After close	+0.3%	+0.9%	-6.1%
Feb 12, 2026After close	After close	-0.6%	+5.8%	-9.4%

RZLT closed higher after 3 of its last 4 reports.

RZLT has 2 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on RZLT, and all 14 on every stock.Get in free →

RZLT RSI today: 50.1, below its 50-day, above its 200-day

Not scored

RSI 50.1, MACD above signal, below its 50-day, above its 200-day. Not scored.13 readings

The deep dive on RZLT

What it does and how it makes money2 findingsFor Pro members2 findings on what RZLT does and how it makes money, for Pro members
Where it stands1 finding1 offering of shares or notes since Apr 2025.SEC filing · Apr 23, 2025
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades RZLT, for Pro members

4 more findings on RZLT, each with its source, for Pro members.

RZLT share count over time

1% more shares than a year earlier.

Weighted shares, quarter to Sep 30, 2026, both from one filing

Shares of RZLT outstanding, as filed
Shares outstanding	As of
96.7M	Nov 2, 2026
96.7M	Sep 21, 2026
96.3M	May 8, 2026
95.7M	Feb 9, 2026

Offerings, shelves, and splits of RZLT, from its filings
From its filings	Filed
Registered shares for a later sale (S-3)	Nov 5, 2026
Registered shares for a later sale (S-3ASR)	Dec 5, 2025
Registered shares for a later sale (S-3)	Jul 17, 2025
Priced a sale of shares	Apr 23, 2025

3 more offerings on file, for Pro members.

RZLT's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Nevan C. ElamCEO · 1 trade
Daron EvansCFO · 4 trades
Sunil Ratilal KarnawatChief Commercial Officer · 2 trades
Brian Kenneth RobertsChief Medical Officer · 1 trade
Wladimir HogenhuisDirector · 1 trade
Erik HarrisDirector · no trades on file
Gil M. LabrucherieDirector · no trades on file
Nerissa KreherDirector · no trades on file

2 more officers and directors file at RZLT.

See insider trades by person

Which ETFs hold RZLT?

In ETFs: RZLT is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Rezolute

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

58 employeesRedwood City, CArezolutebio.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on RZLT and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn RZLT's score around: 7 things
12 more filings explained, a plain line each
Real-⁠time prices, no delay

See RZLT's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: RZLT's Quality Score is -4 (Poor), #81 of 90 in Pharma.

What does RZLT's Quality Score say?

RZLT scores -4 today, which Breakaway calls Poor. It is #81 of 90 in Pharma by Quality Score, with 2 of 14 chart checks firing. Down 61% in a year while the S&P 500 rose 12%; up 355% over three years. Cash lasts about 5 quarters at its spending (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is RZLT's Quality Score?

RZLT scores -4 today, which Breakaway calls Poor (below zero). That is #81 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RZLT's -4.

When does RZLT report earnings?

Expected to report Thu Feb 11, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. RZLT closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.